Celcuity Inc (CELC):企業の製品パイプライン分析

◆英語タイトル:Celcuity Inc (CELC) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME2510587PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥243,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Celcuity Inc (Celcuity) is a cellular analysis company that develops companion diagnostic tests to identify new patient populations for targeted therapies. The company’s CELx signaling function diagnostic platform utilizes a patient’s living tumor cells to identify the specific abnormal cellular activity. It also develops CELx multi-pathway (MP) signaling function test for breast cancer which measures HER1, HER2, HER3, and c-Met signaling activity in a patient’s live tumor cells. The company partners with pharmaceutical companies to evaluate the efficacy of targeted therapies in patients diagnosed with cancer. Celcuity is headquartered in Minneapolis, Minnesota, the US

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Celcuity Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Celcuity Inc Company Overview
Celcuity Inc Company Snapshot
Celcuity Inc Pipeline Products and Ongoing Clinical Trials Overview
Celcuity Inc – Pipeline Analysis Overview
Celcuity Inc – Key Facts
Celcuity Inc – Major Products and Services
Celcuity Inc Pipeline Products by Development Stage
Celcuity Inc Pipeline Products Overview
CELsignia Test – Bladder Cancer
CELsignia Test – Bladder Cancer Product Overview
CELsignia Test – Breast Cancer
CELsignia Test – Breast Cancer Product Overview
CELsignia Test – Colon Cancer
CELsignia Test – Colon Cancer Product Overview
CELsignia Test – Kidney Cancer
CELsignia Test – Kidney Cancer Product Overview
CELsignia Test – Lung Cancer
CELsignia Test – Lung Cancer Product Overview
CELsignia Test – Ovarian Cancer
CELsignia Test – Ovarian Cancer Product Overview
CELx HSF Test
CELx HSF Test Product Overview
CELx Test – Hematological Cancer
CELx Test – Hematological Cancer Product Overview
Celcuity Inc – Key Competitors
Celcuity Inc – Key Employees
Celcuity Inc – Locations And Subsidiaries
Head Office
Recent Developments
Celcuity Inc, Recent Developments
Dec 11, 2019: Celcuity presents results at the 2019 San Antonio Breast Cancer Symposium evaluating a sub-group of PIK3CA WT breast cancer patients who have hyperactive signaling tumors responsive to PI3K inhibitors
Dec 05, 2019: Celcuity announces appointment of Richard Buller to Board of Directors
Nov 07, 2019: Celcuity reports third quarter 2019 financial results
Sep 09, 2019: Celcuity announces appointment of Eric Lindquist as chief business officer
Aug 08, 2019: Celcuity reports second quarter 2019 financial results
May 20, 2019: Celcuity names Leo Furcht to Board of Directors
May 07, 2019: Celcuity reports first quarter 2019 financial results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Celcuity Inc Pipeline Products and Ongoing Clinical Trials Overview
Celcuity Inc Pipeline Products by Equipment Type
Celcuity Inc Pipeline Products by Indication
Celcuity Inc, Key Facts
Celcuity Inc, Major Products and Services
Celcuity Inc Number of Pipeline Products by Development Stage
Celcuity Inc Pipeline Products Summary by Development Stage
CELsignia Test - Bladder Cancer - Product Status
CELsignia Test - Bladder Cancer - Product Description
CELsignia Test - Breast Cancer - Product Status
CELsignia Test - Breast Cancer - Product Description
CELsignia Test - Colon Cancer - Product Status
CELsignia Test - Colon Cancer - Product Description
CELsignia Test - Kidney Cancer - Product Status
CELsignia Test - Kidney Cancer - Product Description
CELsignia Test - Lung Cancer - Product Status
CELsignia Test - Lung Cancer - Product Description
CELsignia Test - Ovarian Cancer - Product Status
CELsignia Test - Ovarian Cancer - Product Description
CELx HSF Test - Product Status
CELx HSF Test - Product Description
CELx Test - Hematological Cancer - Product Status
CELx Test - Hematological Cancer - Product Description
Celcuity Inc, Key Employees
Glossary

★海外企業調査レポート[Celcuity Inc (CELC):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Formula Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Formula Pharmaceuticals Inc (Formula Pharmaceuticals) is a biopharmaceutical company that develops chimeric antigen receptor immunotherapy for oncology and autoimmune diseases. The company provides its pipeline products such as CIK-CAR.CD19, used as B-lymphocyte surface antigen; CIK-CAR.CD33 …
  • pSivida Corp (PSDV)-医療機器分野:企業M&A・提携分析
    Summary pSivida Corp (pSivida) is a specialty pharmaceutical company that offers development of miniaturized, sustained-release drug delivery products and technologies. The company’s products include iluvien, retisert and durasert. Its durasert is an injectable, miniaturized, sustained-release drug …
  • juwi AG:電力:M&Aディール及び事業提携情報
    Summary juwi AG (juwi) a subsidiary of MVV Energie AG, is a renewable energy company that offers project development and engineering procurement and construction services; and products and solutions for the energy turnaround. It offers whole-scale project development services for the planning and co …
  • OncoSec Medical Inc (ONCS)-医療機器分野:企業M&A・提携分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • A. Menarini Industrie Farmaceutiche Riunite Srl:製薬・医療:M&Aディール及び事業提携情報
    Summary A. Menarini Industrie Farmaceutiche Riunite Srl (Menarini), formerly Farmacia Internazionale, is a biopharmaceutical company that undertakes the research, development and manufacture of several pharmaceutical products in various dosage forms. The company’s products portfolio is focused on a …
  • Oil and Natural Gas Corporation Limited:戦略・SWOT・企業財務分析
    Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Toro Energy Limited (TOE):企業の財務・戦略的SWOT分析
    Toro Energy Limited (TOE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lloyds Banking Group Plc:企業のM&A・事業提携・投資動向
    Lloyds Banking Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lloyds Banking Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Bayer AG:企業の戦略・SWOT・財務情報
    Bayer AG - Strategy, SWOT and Corporate Finance Report Summary Bayer AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Lay Hong Berhad (LAYHONG):企業の財務・戦略的SWOT分析
    Lay Hong Berhad (LAYHONG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sysmex Corp (6869):製薬・医療:M&Aディール及び事業提携情報
    Summary Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory inform …
  • Duravit AG:企業の戦略・SWOT・財務情報
    Duravit AG - Strategy, SWOT and Corporate Finance Report Summary Duravit AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cable & Wireless Communications Ltd:企業の戦略的SWOT分析
    Cable & Wireless Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Andeavor Corporation:企業の戦略・SWOT・財務情報
    Andeavor Corporation - Strategy, SWOT and Corporate Finance Report Summary Andeavor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Skanray Technologies Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Skanray Technologies Pvt Ltd (Skanray) is a medical equipment manufacturing company. It provides high frequency x-ray imaging systems, critical care devices, and primary healthcare and telemedicine compatible devices. The company’s product categories include defibrillator, ventilators, surgi …
  • EyeGate Pharmaceuticals Inc (EYEG):企業の財務・戦略的SWOT分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontop …
  • Liechtensteinische Landesbank Ag
    Liechtensteinische Landesbank Ag - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Critical Outcome Technologies Inc (COT)-製薬・医療分野:企業M&A・提携分析
    Summary Critical Outcome Technologies Inc (COTI) is a biopharmaceutical company that develops targeted therapeutics with focus on oncology. The company’s lead program COTI-2 is a novel small molecule activator of misfolded mutant p53 proteins for the treatment of ovarian and other gynecological canc …
  • Acushnet Holdings Corp. (GOLF):企業の財務・戦略的SWOT分析
    Acushnet Holdings Corp. (GOLF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆